Evaluation of the Efficacy of Ultrasound-Guided Posterior Tibial Nerve Pulsed Radiofrequency Treatment in the Management of Diabetic Neuropathic Pain.

IF 1.4 4区医学 Q3 ACOUSTICS

Journal of Clinical Ultrasound Pub Date : 2025-08-29 DOI:10.1002/jcu.70056

Gozde Erol, Gevher Rabia Genc Perdecioglu, Gokhan Yildiz, Damla Yuruk, Ufuk Turan, Ismet Melek, Omer Taylan Akkaya

{"title":"Evaluation of the Efficacy of Ultrasound-Guided Posterior Tibial Nerve Pulsed Radiofrequency Treatment in the Management of Diabetic Neuropathic Pain.","authors":"Gozde Erol, Gevher Rabia Genc Perdecioglu, Gokhan Yildiz, Damla Yuruk, Ufuk Turan, Ismet Melek, Omer Taylan Akkaya","doi":"10.1002/jcu.70056","DOIUrl":null,"url":null,"abstract":"Objectives: To evaluate the efficacy of ultrasound (US)-guided pulsed radiofrequency (PRF) treatment of posterior tibial nerve (PTN) in patients with painful diabetic peripheral neuropathy (PDPN) refractory to pharmacotherapy.Methods: US-guided PTN-PRF treatment was applied for 240 s at a maximum temperature of 42°C with a pulse width of 20 ms in 55 patients with PDPN. The primary aim of this study was to evaluate the efficacy of US-guided PRF treatment of the PTN on pain scores using a Visual Analog Scale (VAS) in patients with type 2 diabetes mellitus who had pharmacotherapy-resistant PDPN. The secondary aims were to evaluate the impact of PRF on sleep quality using the Jenkins Sleep Scale (JSS), assess neuropathic pain severity using the PainDETECT Questionnaire (PDQ), and determine the incidence of procedure-related adverse events.Results: US-guided PTN-PRF provided effective pain reduction at both 1 and 3 months compared with baseline. The VAS score reduction rate was 62.5% at 1 month and 37.5% at 3 months post-treatment. PTN-PRF improved sleep disorders by providing pain control. The JSS score reduction rate was 43.75% at 1 month and 25% at 3 months after treatment. No procedure-related adverse events were reported in any participants.Conclusion: US-guided PTN-PRF treatment is an effective and safe method for pain control and sleep quality improvement in patients with PDPN refractory to pharmacological treatment.","PeriodicalId":15386,"journal":{"name":"Journal of Clinical Ultrasound","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Ultrasound","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jcu.70056","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ACOUSTICS","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: To evaluate the efficacy of ultrasound (US)-guided pulsed radiofrequency (PRF) treatment of posterior tibial nerve (PTN) in patients with painful diabetic peripheral neuropathy (PDPN) refractory to pharmacotherapy.

Methods: US-guided PTN-PRF treatment was applied for 240 s at a maximum temperature of 42°C with a pulse width of 20 ms in 55 patients with PDPN. The primary aim of this study was to evaluate the efficacy of US-guided PRF treatment of the PTN on pain scores using a Visual Analog Scale (VAS) in patients with type 2 diabetes mellitus who had pharmacotherapy-resistant PDPN. The secondary aims were to evaluate the impact of PRF on sleep quality using the Jenkins Sleep Scale (JSS), assess neuropathic pain severity using the PainDETECT Questionnaire (PDQ), and determine the incidence of procedure-related adverse events.

Results: US-guided PTN-PRF provided effective pain reduction at both 1 and 3 months compared with baseline. The VAS score reduction rate was 62.5% at 1 month and 37.5% at 3 months post-treatment. PTN-PRF improved sleep disorders by providing pain control. The JSS score reduction rate was 43.75% at 1 month and 25% at 3 months after treatment. No procedure-related adverse events were reported in any participants.

Conclusion: US-guided PTN-PRF treatment is an effective and safe method for pain control and sleep quality improvement in patients with PDPN refractory to pharmacological treatment.

查看原文本刊更多论文

超声引导下胫后神经脉冲射频治疗糖尿病神经性疼痛的疗效评价。

目的：评价超声（US）引导脉冲射频（PRF）治疗难治性疼痛性糖尿病周围神经病变（PDPN）患者胫后神经（PTN）的疗效。方法：对55例PDPN患者进行us引导下的PTN-PRF治疗，最高温度42℃，脉宽20 ms，治疗时间240 s。本研究的主要目的是评估美国引导的PRF治疗PTN对2型糖尿病药物治疗抵抗性PDPN患者疼痛评分的影响，使用视觉模拟量表（VAS）。次要目的是使用Jenkins睡眠量表（JSS）评估PRF对睡眠质量的影响，使用PainDETECT问卷（PDQ）评估神经性疼痛的严重程度，并确定手术相关不良事件的发生率。结果：与基线相比，美国引导的PTN-PRF在1个月和3个月时均能有效减轻疼痛。治疗后1个月VAS评分降低率为62.5%，3个月VAS评分降低率为37.5%。PTN-PRF通过提供疼痛控制来改善睡眠障碍。治疗后1个月JSS评分降低率为43.75%，治疗后3个月JSS评分降低率为25%。所有参与者均未报告与手术相关的不良事件。结论：us引导的PTN-PRF治疗对药物治疗难治性PDPN患者是一种有效、安全的疼痛控制和睡眠质量改善方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Ultrasound 医学-核医学

CiteScore

1.90

自引率

0.00%

发文量

248

审稿时长

6 months

期刊介绍： The Journal of Clinical Ultrasound (JCU) is an international journal dedicated to the worldwide dissemination of scientific information on diagnostic and therapeutic applications of medical sonography. The scope of the journal includes--but is not limited to--the following areas: sonography of the gastrointestinal tract, genitourinary tract, vascular system, nervous system, head and neck, chest, breast, musculoskeletal system, and other superficial structures; Doppler applications; obstetric and pediatric applications; and interventional sonography. Studies comparing sonography with other imaging modalities are encouraged, as are studies evaluating the economic impact of sonography. Also within the journal''s scope are innovations and improvements in instrumentation and examination techniques and the use of contrast agents. JCU publishes original research articles, case reports, pictorial essays, technical notes, and letters to the editor. The journal is also dedicated to being an educational resource for its readers, through the publication of review articles and various scientific contributions from members of the editorial board and other world-renowned experts in sonography.